feed,title,long_url,short_url
SeekingAlpha,Stoke Therapeutics shares data from Phase 1/2a trial for STK-001 in Dravet syndrome,https://seekingalpha.com/news/3776966,
SeekingAlpha,Synaptics raises FQ2 guidance to reflect DSP Group contribution,https://seekingalpha.com/news/3776965,
